{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:50:39Z","timestamp":1792590639411,"version":"4.5.0"},"reference-count":47,"publisher":"MyJove Corporation","issue":"232","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/69906","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T23:01:42Z","timestamp":1781391702000},"source":"Crossref","is-referenced-by-count":0,"title":["Bawei Aiguning Granules For Lung Cancer Bone Metastases: A Randomized, Double-blind, Placebo-Controlled Trial Protocol With A Representative Case"],"prefix":"10.3791","author":[{"given":"Peng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chujie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"issue":"3","key":"ref1","first-page":"229","type":"journal-article","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 74 (3), 229\u2013263 (2024).","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"ref2","first-page":"10","type":"journal-article","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H., Jemal, A. Cancer statistics, 2025. CA Cancer J Clin. 75 (1), 10\u201345 (2025).","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41568-018-0081-9","type":"journal-article","article-title":"The lung microenvironment: an important regulator of tumour growth and metastasis","volume":"19","author":"Altorki","year":"2019","unstructured":"Altorki, N. K. et al. The lung microenvironment: an important regulator of tumour growth and metastasis. Nat Rev Cancer. 19 (1), 9\u201331 (2019).","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"18670","DOI":"10.1038\/srep18670","type":"journal-article","article-title":"Natural history of non-small-cell lung cancer with bone metastases","volume":"5","author":"Santini","year":"2015","unstructured":"Santini, D. et al. Natural history of non-small-cell lung cancer with bone metastases. Sci Rep. 5 (1), 18670 (2015).","journal-title":"Sci Rep"},{"issue":"8 Suppl","key":"ref5","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","type":"journal-article","article-title":"Skeletal complications of malignancy","volume":"80","author":"Coleman","year":"1997","unstructured":"Coleman, R. E. Skeletal complications of malignancy. Cancer. 80 (8 Suppl), 1588\u20131594 (1997).","journal-title":"Cancer"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0003-4975(96)00220-2","type":"journal-article","article-title":"Distribution of distant metastases from newly diagnosed non-small cell lung cancer","volume":"62","author":"Quint","year":"1996","unstructured":"Quint, L. E. et al. Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg. 62 (1), 246\u2013250 (1996).","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.lungcan.2007.03.013","type":"journal-article","article-title":"Skeletal metastases in non-small cell lung cancer: a retrospective study","volume":"57","author":"Tsuya","year":"2007","unstructured":"Tsuya, A., Kurata, T., Tamura, K., Fukuoka, M. Skeletal metastases in non-small cell lung cancer: a retrospective study. Lung Cancer. 57 (2), 229\u2013232 (2007).","journal-title":"Lung Cancer"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.lungcan.2015.04.007","type":"journal-article","article-title":"The incidence and clinical impact of bone metastases in non-small cell lung cancer","volume":"89","author":"Kuchuk","year":"2015","unstructured":"Kuchuk, M. et al. The incidence and clinical impact of bone metastases in non-small cell lung cancer. Lung Cancer. 89 (2), 197\u2013202 (2015).","journal-title":"Lung Cancer"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1038\/sj.bjc.6601810","type":"journal-article","article-title":"Prevalence and management of pain in advanced non-small-cell lung cancer","volume":"90","author":"Di Maio","year":"2004","unstructured":"Di Maio, M. et al. Prevalence and management of pain in advanced non-small-cell lung cancer. Br J Cancer. 90 (12), 2288\u20132296 (2004).","journal-title":"Br J Cancer"},{"issue":"6","key":"ref10","first-page":"755","type":"journal-article","article-title":"The hospital burden of disease associated with bone metastases and skeletal-related events","volume":"19","author":"Pockett","year":"2010","unstructured":"Pockett, R. D. et al. The hospital burden of disease associated with bone metastases and skeletal-related events. Eur J Cancer Care. 19 (6), 755\u2013760 (2010).","journal-title":"Eur J Cancer Care"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1093\/annonc\/mds009","type":"journal-article","article-title":"Bone matters in lung cancer","volume":"23","author":"Brodowicz","year":"2012","unstructured":"Brodowicz, T. et al. Bone matters in lung cancer. Ann Oncol. 23 (9), 2215\u20132222 (2012).","journal-title":"Ann Oncol"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.annonc.2020.07.019","type":"journal-article","article-title":"Bone health in cancer: ESMO Clinical Practice Guidelines","volume":"31","author":"Coleman","year":"2020","unstructured":"Coleman, R. et al. Bone health in cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 31 (12), 1650\u20131663 (2020).","journal-title":"Ann Oncol"},{"issue":"9768","key":"ref13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","type":"journal-article","article-title":"Denosumab versus zoledronic acid for bone metastases","volume":"377","author":"Fizazi","year":"2011","unstructured":"Fizazi, K. et al. Denosumab versus zoledronic acid for bone metastases. Lancet. 377 (9768), 813\u2013822 (2011).","journal-title":"Lancet"},{"issue":"35","key":"ref14","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","type":"journal-article","article-title":"Denosumab vs zoledronic acid in breast cancer","volume":"28","author":"Stopeck","year":"2010","unstructured":"Stopeck, A. T. et al. Denosumab vs zoledronic acid in breast cancer. J Clin Oncol. 28 (35), 5132\u20135139 (2010).","journal-title":"J Clin Oncol"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3111\/13696998.2012.719054","type":"journal-article","article-title":"Cost-effectiveness of denosumab vs zoledronic acid","volume":"16","author":"Snedecor","year":"2013","unstructured":"Snedecor, S. J. et al. Cost-effectiveness of denosumab vs zoledronic acid. J Med Econ. 16 (1), 19\u201329 (2013).","journal-title":"J Med Econ"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"915","DOI":"10.6004\/jnccn.2020.7668","type":"journal-article","article-title":"Bone metastases and SREs in NSCLC treated with immunotherapy","volume":"19","author":"Qin","year":"2021","unstructured":"Qin, A. et al. Bone metastases and SREs in NSCLC treated with immunotherapy. J Natl Compr Canc Netw. 19 (8), 915\u2013921 (2021).","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/cam4.2108","type":"journal-article","article-title":"Traditional Chinese medicine as a cancer treatment","volume":"8","author":"Xiang","year":"2019","unstructured":"Xiang, Y. et al. Traditional Chinese medicine as a cancer treatment. Cancer Med. 8 (5), 1958\u20131975 (2019).","journal-title":"Cancer Med"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jama.2018.8907","type":"journal-article","article-title":"Effect of acupuncture vs sham acupuncture","volume":"320","author":"Hershman","year":"2018","unstructured":"Hershman, D. L. et al. Effect of acupuncture vs sham acupuncture. JAMA. 320 (2), 167\u2013176 (2018).","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1277243","DOI":"10.3389\/fimmu.2023.1277243","type":"journal-article","article-title":"Traditional Chinese medicine and cancer immunotherapy","volume":"14","author":"Miao","year":"2023","unstructured":"Miao, K. et al. Traditional Chinese medicine and cancer immunotherapy. Front Immunol. 14, 1277243 (2023).","journal-title":"Front Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"7197339","DOI":"10.1155\/prm\/7197339","type":"journal-article","article-title":"TCM in advanced cancer symptom management","volume":"2026","author":"Jiao","year":"2026","unstructured":"Jiao, C. et al. TCM in advanced cancer symptom management. Pain Res Manag. 2026, 7197339 (2026).","journal-title":"Pain Res Manag"},{"key":"ref21","type":"journal-article","article-title":"Omics technologies in TCM for bone diseases","volume":"16","author":"Cai","year":"2025","unstructured":"Cai, W. et al. Omics technologies in TCM for bone diseases. Front Pharmacol. 16 (2025).","journal-title":"Front Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1638629","DOI":"10.3389\/fendo.2025.1638629","type":"journal-article","article-title":"TCM therapeutics for osteoporosis","volume":"16","author":"An","year":"2025","unstructured":"An, Z. et al. TCM therapeutics for osteoporosis. Front Endocrinol. 16, 1638629 (2025).","journal-title":"Front Endocrinol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2147\/TCRM.S523279","type":"journal-article","article-title":"Challenges in TCM clinical trials","volume":"21","author":"Hu","year":"2025","unstructured":"Hu, Y. et al. Challenges in TCM clinical trials. Ther Clin Risk Manag. 21, 1085\u20131094 (2025).","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"ref24","first-page":"575","type":"journal-article","article-title":"Quality consistency evaluation of TCM granules","volume":"17","author":"Zhao","year":"2024","unstructured":"Zhao, J. et al. Quality consistency evaluation of TCM granules. Chin Herb Med. 17 (3), 575\u2013583 (2024).","journal-title":"Chin Herb Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.2147\/TCRM.S557457","type":"journal-article","article-title":"TRIPLE-TCM trial framework","volume":"21","author":"Zhao","year":"2025","unstructured":"Zhao, F. Y. et al. TRIPLE-TCM trial framework. Ther Clin Risk Manag. 21, 1521\u20131534 (2025).","journal-title":"Ther Clin Risk Manag"},{"issue":"8","key":"ref26","first-page":"3571","type":"journal-article","article-title":"TCM with chemotherapy in NSCLC: meta-analysis","volume":"28","author":"Yang","year":"2020","unstructured":"Yang, J. et al. TCM with chemotherapy in NSCLC: meta-analysis. Support Care Cancer. 28 (8), 3571\u20133579 (2020).","journal-title":"Support Care Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1429194","DOI":"10.3389\/fonc.2024.1429194","type":"journal-article","article-title":"Research trends on bone metastases in lung cancer","volume":"14","author":"Rui","year":"2024","unstructured":"Rui, Z. et al. Research trends on bone metastases in lung cancer. Front Oncol. 14, 1429194 (2024).","journal-title":"Front Oncol"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"e0234927","DOI":"10.1371\/journal.pone.0234927","type":"journal-article","article-title":"Bone metastasis and SREs: Korean study","volume":"15","author":"Hong","year":"2020","unstructured":"Hong, S. et al. Bone metastasis and SREs: Korean study. PLoS One. 15 (7), e0234927 (2020).","journal-title":"PLoS One"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/JTO.0b013e31819518fc","type":"journal-article","article-title":"Management of bone metastases in lung cancer","volume":"4","author":"Husaini","year":"2009","unstructured":"Husaini, H. A. et al. Management of bone metastases in lung cancer. J Thorac Oncol. 4 (2), 251\u2013259 (2009).","journal-title":"J Thorac Oncol"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1200\/JCO.1999.17.3.846","type":"journal-article","article-title":"Pamidronate reduces skeletal morbidity","volume":"17","author":"Theriault","year":"1999","unstructured":"Theriault, R. L. et al. Pamidronate reduces skeletal morbidity. J Clin Oncol. 17 (3), 846\u2013854 (1999).","journal-title":"J Clin Oncol"},{"issue":"24","key":"ref31","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199612123352401","type":"journal-article","article-title":"Pamidronate in breast cancer bone metastases","volume":"335","author":"Hortobagyi","year":"1996","unstructured":"Hortobagyi, G. N. et al. Pamidronate in breast cancer bone metastases. N Engl J Med. 335 (24), 1785\u20131791 (1996).","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e081124","DOI":"10.1136\/bmj-2024-081124","type":"journal-article","article-title":"CONSORT 2025 explanation and elaboration","volume":"389","author":"Hopewell","year":"2025","unstructured":"Hopewell, S. et al. CONSORT 2025 explanation and elaboration. BMJ. 389, e081124 (2025).","journal-title":"BMJ"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","type":"journal-article","article-title":"Empirical evidence of bias","volume":"273","author":"Schulz","year":"1995","unstructured":"Schulz, K. F. et al. Empirical evidence of bias. JAMA. 273 (5), 408\u2013412 (1995).","journal-title":"JAMA"},{"issue":"7192","key":"ref34","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1136\/bmj.318.7192.1209","type":"journal-article","article-title":"Treatment allocation in trials","volume":"318","author":"Altman","year":"1999","unstructured":"Altman, D. G., Bland, J. M. Treatment allocation in trials. BMJ. 318 (7192), 1209 (1999).","journal-title":"BMJ"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12874-021-01468-7","type":"journal-article","article-title":"Impact of limited sample size on survival extrapolation","volume":"21","author":"Beca","year":"2021","unstructured":"Beca, J. M. et al. Impact of limited sample size on survival extrapolation. BMC Med Res Methodol. 21, 282 (2021).","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"ref36","type":"journal-article","article-title":"Extrapolation beyond trials","volume":"1","author":"Latimer","year":"2022","unstructured":"Latimer, N. R., Adler, A. I. Extrapolation beyond trials. BMJ Med. 1 (1) (2022).","journal-title":"BMJ Med"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"e186019","DOI":"10.1001\/jamanetworkopen.2018.6019","type":"journal-article","article-title":"Long-term follow-up of randomized trials","volume":"1","author":"Fitzpatrick","year":"2018","unstructured":"Fitzpatrick, T. et al. Long-term follow-up of randomized trials. JAMA Netw Open. 1 (8), e186019 (2018).","journal-title":"JAMA Netw Open"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1186\/s12909-025-07570-4","type":"journal-article","article-title":"Participation in clinical research training","volume":"25","author":"Chen","year":"2025","unstructured":"Chen, Y. et al. Participation in clinical research training. BMC Med Educ. 25, 1226 (2025).","journal-title":"BMC Med Educ"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"111998","DOI":"10.1016\/j.jclinepi.2025.111998","type":"journal-article","article-title":"Impact of placebo controls in trials","volume":"188","author":"Laursen","year":"2025","unstructured":"Laursen, D. R. T. et al. Impact of placebo controls in trials. J Clin Epidemiol. 188, 111998 (2025).","journal-title":"J Clin Epidemiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bonr.2016.09.001","type":"journal-article","article-title":"Flavonoids from Drynariae Rhizoma prevent bone loss","volume":"5","author":"Song","year":"2016","unstructured":"Song, S. et al. Flavonoids from Drynariae Rhizoma prevent bone loss. Bone Rep. 5, 262\u2013273 (2016).","journal-title":"Bone Rep"},{"key":"ref41","type":"journal-article","article-title":"Drynariae Rhizoma and OPG\/RANKL axis","volume":"13","author":"Xu","year":"2022","unstructured":"Xu, T. et al. Drynariae Rhizoma and OPG\/RANKL axis. Front Pharmacol. 13 (2022).","journal-title":"Front Pharmacol"},{"key":"ref42","type":"journal-article","article-title":"Bone and fat balance regulation","volume":"13","author":"Qin","year":"2024","unstructured":"Qin, X. Y. et al. Bone and fat balance regulation. Aging. 13 (2024).","journal-title":"Aging"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.molimm.2020.11.014","type":"journal-article","article-title":"Astragaloside IV and macrophage polarization","volume":"130","author":"Wang","year":"2021","unstructured":"Wang, X. et al. Astragaloside IV and macrophage polarization. Mol Immunol. 130, 113\u2013121 (2021).","journal-title":"Mol Immunol"},{"issue":"10","key":"ref44","doi-asserted-by":"crossref","first-page":"e31450","DOI":"10.1016\/j.heliyon.2024.e31450","type":"journal-article","article-title":"Astragaloside IV inhibits cancer metastasis","volume":"10","author":"Zhou","year":"2024","unstructured":"Zhou, J. et al. Astragaloside IV inhibits cancer metastasis. Heliyon. 10 (10), e31450 (2024).","journal-title":"Heliyon"},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.gendis.2023.02.022","type":"journal-article","article-title":"Anti-cancer effects of Panax notoginseng","volume":"10","author":"Thorpe","year":"2023","unstructured":"Thorpe, E. M. et al. Anti-cancer effects of Panax notoginseng. Genes Dis. 10 (6), 2229\u20132232 (2023).","journal-title":"Genes Dis"},{"issue":"10","key":"ref46","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1007\/s00296-011-2083-8","type":"journal-article","article-title":"Anti-inflammatory effects of Clematis chinensis","volume":"32","author":"Peng","year":"2012","unstructured":"Peng, C. et al. Anti-inflammatory effects of Clematis chinensis. Rheumatol Int. 32 (10), 3119\u20133125 (2012).","journal-title":"Rheumatol Int"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"105563","DOI":"10.1016\/j.intimp.2019.04.010","type":"journal-article","article-title":"Protective effects of Clematichinenoside AR","volume":"75","author":"Xiong","year":"2019","unstructured":"Xiong, Y. et al. Protective effects of Clematichinenoside AR. Int Immunopharmacol. 75, 105563 (2019).","journal-title":"Int Immunopharmacol"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/69906\/bawei-aiguning-granules-for-lung-cancer-bone-metastases-randomized","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:33:24Z","timestamp":1792589604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/69906\/bawei-aiguning-granules-for-lung-cancer-bone-metastases-randomized"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":47,"journal-issue":{"issue":"232","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/69906","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]}}}